Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
Xenon Pharmaceuticals Inc. net margin for the quarter ending 2025-03-31 was -867.29%.
Xenon Pharmaceuticals Inc. net margin for the quarter ending 2022-09-30 was -28143.94%, a change of -27953.82% year-over-year.
Xenon Pharmaceuticals Inc. net margin for the quarter ending 2022-06-30 was -5813.06%, a change of -4816.26% year-over-year.
Xenon Pharmaceuticals Inc. net margin for the quarter ending 2022-03-31 was -224.39%, a change of 137.34% year-over-year.
Xenon Pharmaceuticals Inc. net margin for fiscal 2025 was -4612.13%.
Xenon Pharmaceuticals Inc. net margin for fiscal 2022 was -1328.95%, a change of -901.10% from fiscal 2021.
Xenon Pharmaceuticals Inc. net margin for fiscal 2021 was -427.85%, a change of -338.20% from fiscal 2020.
Xenon Pharmaceuticals Inc. net margin for fiscal 2020 was -89.65%, a change of 519.44% from fiscal 2019.